skip to content
Detailed Quote
5i Report
Rating
B+

Review of Vitalhub Corp.

SEP 11, 2025 - VHI’s track record of compounding capital at a high rate as an acquisitive company is still early but quite solid. We think that if the company manages to execute its acquisitive growth playbook consistently. VHI can continue to grow revenue and earnings in the double-digit range for many years. We think the company is currently trading at a fair valuation; we would be comfortable holding it for the long term. However, as prospective shareholders, we would not be too aggressive in adding to the position at the current price; we are upgrading our rating to B+.

Download Report
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
Q: There are a number of Small/Mid cap stocks you have liked for a long time and there are others that have recently come into play.

Most of these companies have done very well over time and some have stumbled.

I own a number of these names and other than Goeasy and the negative momentum of software names I have done well…

However, having been bitten a little by some of these names I find it difficult to venture into new names like FLY, TSAT, MDA, ENS, ELVA and others given the almost daily volatility.

What portion of your portfolio would you feel is reasonable for Small/Mid cap names? And what are your key metrics when you review or recommend these small to mid size companies?

Given all of that what would be your top 5 new names you like in today’s market?

Thanks
Tim
Read Answer Asked by Timothy on May 12, 2026
Q: The above equities are missing from my portfolio. Please rank the above in terms of growth potential over the next 3 - 5 years, adding in some consideration as to their current pricing.
Read Answer Asked by Claus on May 12, 2026
Insiders
Share Information
News and Media